Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 22.34
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers vitamin D calcium chewable tablets. The company was founded in 2005 and is based in Qingdao, China.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Data is available to registered users only
Target Price
The average target price of 301015.SZ is 24 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
Data is available to registered users only
Buy
Sell